News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Gilles Freyer

Articles by Gilles Freyer

19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

ByLowell Hart,Seock-Ah Im,Sara M. Tolaney, MD, MPH,Mario Campone,Timothy Pluard,Berta Sousa,Gilles Freyer,Thomas Decker,Kevin Kalinsky, MD, MS,Astrid Thuerigen,Melissa Gao,Huilin Hu,Sherko Kümmel

August 9th 2024

Latest Updated Articles

Trending on CancerNetwork

Withdrawal Planned for Second-Line Lurbinectedin in SCLC Indication

Clinical Implications of Earlier CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Prophylactic Cranial Irradiation Improves Survival in Limited-Stage SCLC

Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer

CARTITUDE-4 Supports Earlier CAR-T Use in Relapsed/Refractory Multiple Myeloma